Circulating YKL-40 in myelofibrosis a potential novel biomarker of disease activity and the inflammatory state
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating YKL-40 in myelofibrosis a potential novel biomarker of disease activity and the inflammatory state
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF HAEMATOLOGY
Volume 93, Issue 3, Pages 224-228
Publisher
Wiley
Online
2014-04-02
DOI
10.1111/ejh.12332
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Potential Association Between TLR4 and Chitinase 3-Like 1 (CHI3L1/YKL-40) Signaling on Colonic Epithelial Cells in Inflammatory Bowel Disease and Colitis-Associated Cancer
- (2013) A. Kamba et al. CURRENT MOLECULAR MEDICINE
- The role of cytokines in the initiation and progression of myelofibrosis
- (2013) Hans C. Hasselbalch CYTOKINE & GROWTH FACTOR REVIEWS
- The chitinase-like protein YKL-40: A possible biomarker of inflammation and airway remodeling in severe pediatric asthma
- (2013) Jon R. Konradsen et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- YKL-40 Protein Levels and Clinical Outcome of Human Endometrial Cancer
- (2013) C Peng et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Elevated C-reactive protein is associated with shortened leukemia-free survival in patients with myelofibrosis
- (2013) T Barbui et al. LEUKEMIA
- Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
- (2013) J. Nangalia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
- (2013) Thorsten Klampfl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasma cytokines in polycythemia vera: Phenotypic correlates, prognostic relevance, and comparison with myelofibrosis
- (2012) Rakhee Vaidya et al. AMERICAN JOURNAL OF HEMATOLOGY
- Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer?
- (2012) H. C. Hasselbalch BLOOD
- Endothelial dysfunction : the early predictor of atherosclerosis
- (2012) Mashudu Mudau et al. Cardiovascular Journal of Africa
- Gene expression profiling with principal component analysis depicts the biological continuum from essential thrombocythemia over polycythemia vera to myelofibrosis
- (2012) Vibe Skov et al. EXPERIMENTAL HEMATOLOGY
- Molecular profiling of peripheral blood cells from patients with polycythemia vera and related neoplasms: Identification of deregulated genes of significance for inflammation and immune surveillance
- (2012) Vibe Skov et al. LEUKEMIA RESEARCH
- Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?
- (2012) Hans Carl Hasselbalch LEUKEMIA RESEARCH
- Chitinase 3-Like-1 Expression in Colonic Epithelial Cells as a Potentially Novel Marker for Colitis-Associated Neoplasia
- (2011) Chun-Chuan Chen et al. AMERICAN JOURNAL OF PATHOLOGY
- Chronic myeloproliferative neoplasms and subsequent cancer risk: a Danish population-based cohort study
- (2011) H. Frederiksen et al. BLOOD
- YKL-40 Protein is a Marker of Asthma
- (2011) Krzysztof Specjalski et al. JOURNAL OF ASTHMA
- Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study
- (2011) Ayalew Tefferi et al. JOURNAL OF CLINICAL ONCOLOGY
- A YKL-40-Neutralizing Antibody Blocks Tumor Angiogenesis and Progression: A Potential Therapeutic Agent in Cancers
- (2011) M. Faibish et al. MOLECULAR CANCER THERAPEUTICS
- Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms
- (2010) N. H. Thoennissen et al. BLOOD
- Autoimmunity and the risk of myeloproliferative neoplasms
- (2010) S. Y. Kristinsson et al. HAEMATOLOGICA
- Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3
- (2010) T. Barbui et al. HAEMATOLOGICA
- Increased Circulating and Visceral Adipose Tissue Expression Levels of YKL-40 in Obesity-Associated Type 2 Diabetes Are Related to Inflammation: Impact of Conventional Weight Loss and Gastric Bypass
- (2010) Victoria Catalán et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
- (2010) A Tefferi LEUKEMIA
- Janus kinase 2 mutations in Philadelphia negative chronic myeloproliferative disorders: Clinical implications
- (2009) Anna D. Panani CANCER LETTERS
- Serum levels of YKL-40 increases in patients with acute myocardial infarction
- (2009) Camilla Nøjgaard et al. CORONARY ARTERY DISEASE
- Plasma YKL-40: a potential new cancer biomarker?
- (2009) Julia S Johansen et al. Future Oncology
- Plasma YKL-40: A BMI-Independent Marker of Type 2 Diabetes
- (2008) A. R. Nielsen et al. DIABETES
- YKL-40, a Marker of Inflammation and Endothelial Dysfunction, Is Elevated in Patients With Type 1 Diabetes and Increases With Levels of Albuminuria
- (2008) C. N. Rathcke et al. DIABETES CARE
- High serum YKL-40 concentration is associated with severe bone disease in newly diagnosed multiple myeloma patients
- (2008) Anne K. Mylin et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Elevated Plasma YKL-40 Predicts Increased Risk of Gastrointestinal Cancer and Decreased Survival After Any Cancer Diagnosis in the General Population
- (2008) Julia S. Johansen et al. JOURNAL OF CLINICAL ONCOLOGY
- Low JAK2V617F allele burden in primary myelofibrosis, compared to either a higher allele burden or unmutated status, is associated with inferior overall and leukemia-free survival
- (2008) A Tefferi et al. LEUKEMIA
- Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal
- (2008) A M Vannucchi et al. LEUKEMIA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started